¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2023-10-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2023-10-22
±³À°ÀÏÀÚ : 2023-10-22
±³À°Àå¼Ò : ½ÅÃ̼¼ºê¶õ½ºº´¿ø ¿¡ºñ½¼ÀÇ»ý¸í¿¬±¸¼¾ÅÍ À¯ÀÏÇÑȦ

±³À°ÁÖÁ¦ : 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ(¸íĪº¯°æ 22.9.19 ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ)
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-501-2988  

À̸ÞÀÏ : kates1996@naver.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í [»çÀüµî·Ï] Æò»ýȸ¿ø ¹× Á¤È¸¿ø(Àü¹®ÀÇ):80,000¿ø/ºñȸ¿ø: 100,000¿ø/ÁØȸ¿ø(Àü°øÀÇ ¹× °£È£»ç): 50,000¿ø[ÇöÀåµî·Ï] Æò»ýȸ¿ø ¹× Á¤È¸¿ø(Àü¹®ÀÇ):100,000¿ø/ºñȸ¿ø: 120,000¿ø/ÁØȸ¿ø(Àü°øÀÇ ¹× °£È£»ç): 70,000¿ø* 65¼¼ÀÌ»ó ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 09:00~09:05 °³ÃÖ»ç ¹Ú¿ë·¡(¼º±Õ°üÀÇ´ë)

±âŸ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 09:05~09:10 ÇÁ·Î±×·¥ ¼Ò°³ À±ÇöÁ¶(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 09:10~09:30 Molecular marker and targeted therapy of thyroid carcinoma ¹Ú¿µÁÖ(¼­¿ïÀÇ´ë ³»°ú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 09:30~09:50 2023 The Bethesda System for Reporting Thyroid Cytopathology Á¤Âù±Ç(°¡Å縯ÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 09:50~10:10 2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 10:10~10:30 2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism À¯¿ø»ó(´Ü±¹ÀÇ´ë ³»°ú)

ÈÞ½Ä 10¿ù 22ÀÏ 10:30~10:50 Coffee Break ( )

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 10:50~11:10 Gross and microanatomy of recurrent and  superior laryngeal nerve ¼ÕÇØ¿µ(°üµ¿ÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 11:10~11:30 Basis of IONM(Intraoperative neuro-monitoring) (Setup, procedure, normative electromyography) ±èÁø°æ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 11:30~11:50 Anesthesia protocols and tips for IONM(Intraoperative neuro-monitoring) ±è°æ¹Ì(¿ï»êÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 11:50~12:10 Comparison of needle electrodes and skin electrodes in IONM ÀÌÃÊ·Ï(¿¬¼¼ÀÇ´ë)

½Ä»ç 10¿ù 22ÀÏ 12:10~13:00 Lunch ( )

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 13:00~13:20 Differentiated thyroid carcinoma ÀÌÁØÇù(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 13:20~13:40 Medullary thyroid carcinoma Àå¸íö(´Ü±¹ÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 13:40~14:00 Management of voice change after thyroid surgery À¯Ã¢È¯(±¹¸³¾Ï¼¾ÅÍ À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 14:00~14:20 Operative scar management ÇѺ°(À»ÁöÀÇ´ë ÇǺΰú)

ÈÞ½Ä 10¿ù 22ÀÏ Coffee Break 14:20~14:40 Coffee Break ( )

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 14:40~15:05 Surgical treatment for locally advanced thyroid cancer Á¤ÀºÀç(¼­¿ïÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 15:05~15:30 Adjuvant/neodajuvant therapy for locally advanced thyroid cancer ±è¼®¸ð(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 15:30~15:55 Recent advances in management for locally advanced thyroid cancer ±è±¤¼ø(°¡Å縯ÀÇ´ë)

±âŸ 10¿ù 22ÀÏ À¯ÀÏÇÑȦ 15:55~16:00 Æóȸ»ç ±èÁö¼ö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 10¿ù 22ÀÏ ¼¼¹Ì³ª½Ç 14:40~15:20 Hands-on session : Thyroid FNA (Fine Needle spiration Cytology) & Thyroid RFA (Radiofrequency ablation) 1Â÷ ÃÖÀºÇý(±è¾Ø±Çº´¿ø)

±³À°½Ã°£ 10¿ù 22ÀÏ ¼¼¹Ì³ª½Ç 15:20~16:00 Hands-on session : Thyroid FNA (Fine Needle spiration Cytology) & Thyroid RFA (Radiofrequency ablation) 2Â÷ Àü±â¿ø(¹ÚÈñºØ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2023-10-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2023-10-22
´ÙÀ½±Û 23³â Á¦8ȸ ´ëÇѽÅÀåÇÐȸ Á¦ÁÖÁöȸ Ç÷¾×Åõ¼® ½ÉÆ÷Áö¾ö : 2023-10-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
390 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø 2018³â ¾ÆÁÖ´ëÇб³ ¸¶ÃëÅëÁõÀÇÇаú Ãß°è Çмú´ëȸ : 2018-09-01 0 1,232 2018-08-15
389 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-09-01 0 568 2018-08-15
388 °æ³² â¿ø°æ»ó´ëÇб³º´¿ø 2018³â Áߺΰ泲 ¿¬¼ö±³À° : 2018-09-01 0 921 2018-08-15
387 °­¿ø Á¦19ȸ ´ëÇÑ Ã´Ãß¿Ü°úÇÐȸ ôÃßÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-01 0 851 2018-08-15
386 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-01 0 1,063 2018-08-15
385 ¼­¿ï 2018 ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Ãß°è ÀÓ»ó ¿öÅ©¼¥ : 2018-09-01 0 765 2018-08-15
384 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¤Çü¿Ü°úÁúȯ, ¼Õ»ó, Ä¡·á : 2018-09-01 0 1,458 2018-08-15
383 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-31 0 1,116 2018-08-15
382 ¼­¿ï Çѱ¹Á÷¹«½ºÆ®·¹½ºÇÐȸ 2018³â ÇÏ°èÇмú´ëȸ : 2018-08-31 0 557 2018-08-15
381 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-08-31 0 589 2018-08-15
380 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÎ»êÁöºÎÇÐȸ 8¿ù ¿ù·ÊÁý´ãȸ : 2018-08-30 0 1,242 2018-08-15
379 °­¿ø ¿øÁÖ ¼¼ºê¶õ½º ±âµ¶º´¿ø ±âÃʾȰúÁúȯ / CÇü °£¿° : 2018-08-29 0 2,233 2018-08-15
378 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦154Â÷ ¿ù·Ê¿¬¼ö°­ÁÂ(°¨¿°°ü¸® ¿¬¼ö±³À°) : 2018-08-28 0 615 2018-08-15
377 ¼­¿ï Á¦12ȸ ÁöµµÀü¹®ÀÇ Àü¹®ÇÐȸ(°¡Á¤ÀÇÇÐȸ) ±³À° : 2018-08-25 0 870 2018-08-15
376 ¼­¿ï Á¦13Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ¼­¿ï°æÀÎ(°­¿ø-Á¦ÁÖ)Áöȸ : 2018-08-25 0 762 2018-08-15
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷